Down-regulation of ESRP2 inhibits breast cancer cell proliferation via inhibiting cyclinD1
Abstract Epithelial splicing regulatory protein 2 (ESRP2),an important alternative splicing protein of mRNA, is reported to have a dual role in tumors, which can promote or inhibit the occurrence and development of tumors. However, the function and mechanism of ESRP2 in breast cancer (BC) remain unc...
Saved in:
| Main Authors: | Caiping He, Yuting Chen, Ximin Zhang, Huancun Feng, Yuzhen Rao, Tangyang Ji, Wenya Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-11-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-024-77980-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of ESRP1 in solid tumor development through the regulation of CD44 splicing and EMT processes
by: Lili Wang, et al.
Published: (2025-02-01) -
Notch1 and CyclinD1 expression and significance in jaw ameloblastoma: an immunohistochemical analysis
by: Baoyinbatu Gabiyatu, et al.
Published: (2025-07-01) -
Stem and progenitor cell proliferation are independently regulated by cell type-specific cyclinD genes
by: Mark E. Lush, et al.
Published: (2025-07-01) -
BPS causes abnormal blastocyst development by inhibiting cell proliferation
by: Qing Liu, et al.
Published: (2025-04-01) -
FBXW7 promotes autophagy and inhibits proliferation of oral squamous cell carcinoma
by: Bo Qiu, et al.
Published: (2023-05-01)